S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
A.I. Pioneer Issues Urgent Warning to Americans (Ad)
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Urgent alert: open this for a huge profit potential (Ad)
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bitcoin Rockets To Record High But Buy THIS Instead (Ad)
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Closing prices for crude oil, gold and other commodities
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
A.I. Pioneer Issues Urgent Warning to Americans (Ad)
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Urgent alert: open this for a huge profit potential (Ad)
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bitcoin Rockets To Record High But Buy THIS Instead (Ad)
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Closing prices for crude oil, gold and other commodities
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
A.I. Pioneer Issues Urgent Warning to Americans (Ad)
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Urgent alert: open this for a huge profit potential (Ad)
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bitcoin Rockets To Record High But Buy THIS Instead (Ad)
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Closing prices for crude oil, gold and other commodities
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
A.I. Pioneer Issues Urgent Warning to Americans (Ad)
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Urgent alert: open this for a huge profit potential (Ad)
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bitcoin Rockets To Record High But Buy THIS Instead (Ad)
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Closing prices for crude oil, gold and other commodities
Free Trial

Antibe Therapeutics (ATBPF) News Today

→ Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad)
Free ATBPF Stock Alerts
$0.22
0.00 (0.00%)
(As of 04/19/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesShort Interest
SourceHeadline
businesswire.com logoAntibe Provides Update on CCAA Proceedings
businesswire.com - April 19 at 8:00 AM
finance.yahoo.com logoAntibe Announces TSX Delisting Review
finance.yahoo.com - April 16 at 5:20 PM
businesswire.com logoAntibe Announces Granting of Initial Order Under Companies' Creditors Arrangement Act
businesswire.com - April 9 at 7:00 PM
businesswire.com logoAntibe to File an Application for an Initial Order Under Companies' Creditors Arrangement Act
businesswire.com - April 9 at 7:00 AM
finance.yahoo.com logoAntibe Announces FDA Clinical Hold on Otenaproxesul and Legal Action by Nuance
finance.yahoo.com - April 1 at 8:19 AM
businesswire.com logoAntibe to Present Otenaproxesul PK/PD Results at the ASRA Pain Medicine Meeting
businesswire.com - March 20 at 7:00 AM
businesswire.com logoAntibe to Present Otenaproxesul PK/PD Results at the American Academy of Pain Medicine Meeting
businesswire.com - March 7 at 7:00 AM
marketwatch.com logoAntibe Therapeutics Shares Sink After Arbitration Case Lost
marketwatch.com - March 4 at 2:13 PM
benzinga.com logoAntibe Therapeutics Stock (OTC:ATBPF), Insider Trading Activity
benzinga.com - February 27 at 3:10 PM
finance.yahoo.com logoAntibe Reports Q3 2024 Interim Financial and Operating Results
finance.yahoo.com - February 14 at 8:41 AM
businesswire.com logoAntibe Reports Q3 2024 Interim Financial and Operating Results
businesswire.com - February 14 at 7:00 AM
msn.com logoAntibe Therapeutics reports Q2 results
msn.com - November 13 at 1:28 PM
finance.yahoo.com logoAntibe Reports PK Results of First Clinical Study of Otenaproxesul’s New Formulation
finance.yahoo.com - November 9 at 7:58 AM
finance.yahoo.com logoIs Antibe Therapeutics (TSE:ATE) In A Good Position To Deliver On Growth Plans?
finance.yahoo.com - October 20 at 7:00 AM
finance.yahoo.com logoAntibe Initiates First Clinical Study of Otenaproxesul’s New Formulation
finance.yahoo.com - October 18 at 7:33 AM
finance.yahoo.com logoAntibe Announces Results of 2023 Annual Meeting
finance.yahoo.com - September 8 at 5:59 PM
finance.yahoo.com logoAntibe Reports Q1 2024 Interim Financial and Operating Results
finance.yahoo.com - August 14 at 7:09 AM
finance.yahoo.com logoAntibe Reports 2023 Year-End Results and Business Highlights
finance.yahoo.com - June 29 at 9:49 AM
theglobeandmail.com logoClosing Bell: Antibe Therapeutics Inc down on Tuesday (ATE)
theglobeandmail.com - April 12 at 8:50 AM
theglobeandmail.com logoClosing Bell: Antibe Therapeutics Inc up on Wednesday (ATE)
theglobeandmail.com - April 6 at 2:26 PM
finance.yahoo.com logoAntibe Therapeutics Inc. (ATBPF)
finance.yahoo.com - March 12 at 6:39 PM
markets.businessinsider.com logoMaxim Group Reaffirms Their Buy Rating on Antibe Therapeutics (ATBPF)
markets.businessinsider.com - February 16 at 5:38 PM
markets.businessinsider.com logoEchelon Wealth Partners Reaffirms Their Buy Rating on Antibe Therapeutics (ATBPF)
markets.businessinsider.com - February 15 at 3:45 PM
theglobeandmail.com logoAntibe Therapeutics: Top 25 Undervalued Dividend Stocks on TSX (ATE)
theglobeandmail.com - February 9 at 1:24 PM
theglobeandmail.com logoAntibe Therapeutics: Top 10 Undervalued Healthcare Sector Stocks on TSX (ATE)
theglobeandmail.com - February 7 at 1:37 PM
finance.yahoo.com logoATBPF: On Track to Initiate Phase 2 Trial for Otenaproxesul in 1H23…
finance.yahoo.com - November 22 at 5:16 PM
finance.yahoo.com logoAntibe Provides Development Update for Otenaproxesul
finance.yahoo.com - October 12 at 8:49 AM
finance.yahoo.com logoAntibe Announces Results of 2022 Annual Meeting
finance.yahoo.com - September 9 at 5:23 PM
finance.yahoo.com logoAntibe Academic Collaborator to Present Clinical Data at PAINWeek 2022
finance.yahoo.com - September 6 at 9:12 AM
finance.yahoo.com logoATE.TO: Phase 2 Post-Operative Pain Program to Initiate in Calendar 4Q22…
finance.yahoo.com - July 8 at 3:55 PM
finance.yahoo.com logoWill Antibe Therapeutics (TSE:ATE) Spend Its Cash Wisely?
finance.yahoo.com - July 2 at 10:33 AM
finance.yahoo.com logoAntibe Therapeutics Reports 2022 Year-End Results and Business Highlights
finance.yahoo.com - June 30 at 7:08 AM
nz.finance.yahoo.com logoAntibe Therapeutics to Present at the 2022 Bloom Burton & Co. Healthcare Investor Conference
nz.finance.yahoo.com - April 25 at 7:37 AM
seekingalpha.com logoAntibe Therapeutics GAAP EPS of -$0.09
seekingalpha.com - February 16 at 12:08 AM
finance.yahoo.com logoAntibe Therapeutics Reports Q3 2022 Interim Financial and Operating Results
finance.yahoo.com - February 14 at 8:29 AM
nasdaq.com logoATBPF Real-Time Quotes
nasdaq.com - January 28 at 11:11 PM
finance.yahoo.com logoATE.TO: Development Plan in Place for Otenaproxesul in Acute Pain…
finance.yahoo.com - December 1 at 5:23 PM
msn.com logoBRIEF-Antibe Therapeutics Provides Update On Otenaproxesul And Expanded Drug Pipeline
msn.com - October 14 at 8:04 AM
finance.yahoo.com logoAntibe Therapeutics Provides Update on Otenaproxesul and Expanded Drug Pipeline
finance.yahoo.com - October 14 at 8:04 AM
finance.yahoo.com logoAntibe Therapeutics Announces Results of 2021 Annual Meeting
finance.yahoo.com - August 19 at 6:04 PM
businesswire.com logoAntibe Therapeutics Reports Q1 2022 Interim Financial and Operating Results
businesswire.com - August 17 at 7:56 AM
finance.yahoo.com logoATE.TO: Unexpected Liver Enzyme Elevations Leads to Pause in AME Trial…
finance.yahoo.com - August 4 at 6:03 PM
Get Antibe Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ATBPF and its competitors with MarketBeat's FREE daily newsletter.

Secret Bull Market Starts in This Unusual Sector (Ad)

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here. 

ATBPF Media Mentions By Week

ATBPF Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ATBPF
News Sentiment
▼
0.00

0.52
▲
Average
Medical
News Sentiment

ATBPF News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ATBPF Articles
This Week
▼
2

0
▲
ATBPF Articles
Average Week

Get Antibe Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ATBPF and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (OTCMKTS:ATBPF) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
SHOCKING Crypto Leak…
Crypto 101 Media
Your Money is Not Safe
American Alternative
The #1 Crypto for 2024
InvestorPlace
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets